一种双重准,多面生物相容的纳米药物优化了微环境,以改善腹腔大动脉瘤
Fandi Mo1,2,3,4, Chufan Wang5, Shiyi Li1,2,3,4
1Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Advanced materials (Deerfield Beach, Fla.)
|June 26, 2024
概括
一种新型纳米药物EVMS@R-HNC针对巨细胞和光滑肌细胞治疗腹腔大动脉瘤 (AAA). 这种方法抑制炎症并保持细胞功能,为AAA提供了一个有前途的新疗法.
科学领域:
- 心血管研究研究心血管研究
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
背景情况:
- 腹腔大动脉动脉瘤 (AAA) 是一种致命的心血管疾病,没有有效的药物治疗方法.
- AAA病理生理学涉及M1巨细胞两极分化和光滑肌肉细胞 (SMC) 功能障碍.
- 整体蛋白αvβ3在巨细胞和SMC上表达,呈现出潜在的治疗标.
研究的目的:
- 在AAA中开发和评估一种用于双重向巨细胞和SMC的新型纳米药物.
- 研究EVMS@R-HNC在管理AAA中的治疗潜力.
主要方法:
- 对AAA患者和小鼠模型数据的单细胞RNA测序分析.
- 一种生物相容的纳米药物的设计和合成,EVMS@R-HNC,向整合素αvβ3.
- 在体外和体内评估EVMS@R-HNC在向细胞和调节疾病途径方面的疗效.
主要成果:
- EVMS@R-HNC通过与整合素αvβ3.3结合,成功地向巨细胞和SMC.
- 细胞内释放的Everolimus (EVMS) 抑制M1巨分化,并保持SMC收缩功能.
- 这种纳米药物减轻了AAA特有的炎症级联和免疫失衡.
结论:
- EVMS@R-HNC证明了腹腔大动脉动脉瘤的显著治疗潜力.
- 巨细胞和SMC的双重向为AAA管理提供了一个有希望的策略.
- 这种纳米药物方法解决了AAA进展中的关键病理机制.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


